tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Smart Value
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

VRDN Stock Latest News

Viridian Therapeutics Enters New $300M Sale Agreement
Company AnnouncementsViridian Therapeutics Enters New $300M Sale Agreement
26d ago
8K
VRDN
Viridian Therapeutics Faces Uncertainty Amid Regulatory Approval Challenges
PremiumCompany Announcements
Viridian Therapeutics Faces Uncertainty Amid Regulatory Approval Challenges
27d ago
VRDN
Viridian Therapeutics: Promising Pipeline and Strategic Progress Support Buy Rating
PremiumRatings
Viridian Therapeutics: Promising Pipeline and Strategic Progress Support Buy Rating
28d ago
VRDN
Viridian Therapeutics: Promising Market Position and Growth Prospects Justify Buy Rating
PremiumRatings
Viridian Therapeutics: Promising Market Position and Growth Prospects Justify Buy Rating
1M ago
VRDN
Viridian Therapeutics Reports Strong Progress and Financials
PremiumCompany Announcements
Viridian Therapeutics Reports Strong Progress and Financials
1M ago
VRDN
Viridian Therapeutics: Strong Financials and Promising Clinical Developments Drive Buy Rating
PremiumRatingsViridian Therapeutics: Strong Financials and Promising Clinical Developments Drive Buy Rating
1M ago
VRDN
Viridian Therapeutics Positioned for Market Leadership with Strategic Advancements and Competitive Edge
Premium
Ratings
Viridian Therapeutics Positioned for Market Leadership with Strategic Advancements and Competitive Edge
1M ago
VRDN
Viridian Therapeutics: Strong TED Trial Results and Promising Pipeline Drive Buy Rating
Premium
Ratings
Viridian Therapeutics: Strong TED Trial Results and Promising Pipeline Drive Buy Rating
1M ago
VRDN
Viridian Therapeutics reports Q4 EPS (81c), consensus ($1.04)
PremiumThe Fly
Viridian Therapeutics reports Q4 EPS (81c), consensus ($1.04)
1M ago
VRDN
Viridian Therapeutics promotes Seth Harmon to CFO
PremiumThe Fly
Viridian Therapeutics promotes Seth Harmon to CFO
3M ago
VRDN
Wedbush stays positive on Viridian shares after Acelyrin data
PremiumThe Fly
Wedbush stays positive on Viridian shares after Acelyrin data
3M ago
SLRN
VRDN
Micron downgraded, Block upgraded: Wall Street’s top analyst calls
PremiumThe Fly
Micron downgraded, Block upgraded: Wall Street’s top analyst calls
3M ago
S
AI
Viridian Therapeutics downgraded to Equal Weight from Overweight at Wells Fargo
PremiumThe FlyViridian Therapeutics downgraded to Equal Weight from Overweight at Wells Fargo
3M ago
VRDN
Top 3 Trending Stocks, According to Analysts – 12/18/2024  
Premium
Market News
Top 3 Trending Stocks, According to Analysts – 12/18/2024  
3M ago
NKE
NBIX
Viridian Therapeutics price target raised to $47 from $44 at RBC Capital
Premium
The Fly
Viridian Therapeutics price target raised to $47 from $44 at RBC Capital
3M ago
AMGN
VRDN
Honeywell still exploring alternatives, Capri weighs Versace sale: Morning Buzz
PremiumThe Fly
Honeywell still exploring alternatives, Capri weighs Versace sale: Morning Buzz
3M ago
F
GS
Morning Movers: Viridian and Edgewise jump following successful trials
PremiumThe Fly
Morning Movers: Viridian and Edgewise jump following successful trials
3M ago
F
HON
Viridian Therapeutics Achieves Milestone in Phase 3 Trial
PremiumCompany Announcements
Viridian Therapeutics Achieves Milestone in Phase 3 Trial
3M ago
8K
VRDN
Viridian Therapeutics announces THRIVE-2 trial met primary, secondary endpoints
PremiumThe Fly
Viridian Therapeutics announces THRIVE-2 trial met primary, secondary endpoints
3M ago
VRDN
Viridian Therapeutics initiated with a Buy at TD Cowen
PremiumThe FlyViridian Therapeutics initiated with a Buy at TD Cowen
4M ago
VRDN
Viridian Therapeutics (VRDN) Has Captured Investors’ Attention with Recent Breakthroughs
Premium
Market News
Viridian Therapeutics (VRDN) Has Captured Investors’ Attention with Recent Breakthroughs
4M ago
AMGN
VRDN
Viridian Therapeutics price target raised to $34 from $27 at H.C. Wainwright
Premium
The Fly
Viridian Therapeutics price target raised to $34 from $27 at H.C. Wainwright
5M ago
VRDN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >